Judge ponders stay of ESC ruling; Scientists launch big epigenetics study

Stem Cell Research

A controversial federal court ruling in favor of a temporary restraining order against the use of federal money to back embryonic stem cell research continues to roil labs around the country. A judge is now considering an emergency stay of the injunction. Report

Pioneering Japanese stem cell researcher Shinya Yamanaka has won the prestigious Balzan award for biology. Report

Genetics

An ambitious new international study is searching for the epigenetic signatures that mark the differences in twins. Epigentics has emerged as a big new field in drug discovery. Story

Female induced pluripotent stem (iPS) cells, reprogrammed from human skin cells into cells that have the embryonic-like potential to become any cell in the body, retain an inactive X chromosome, stem cell researchers at UCLA have found. The finding, reported in the journal Cell Stem Cell, could have implications for studying X chromosome-linked diseases such as Rett syndrome, caused by mutations in a gene located on the X chromosome. News

Researchers at the University of California in San Diego say that a gene involved in programmed cell death also plays a role depleting adult stem cells. The insight could help investigators find better ways to treat cancer. Story

Cancer Research

U.K. investigators have gained new insight into the cause and development of triple negative breast cancer that points the way to new, personalized therapies. Story

A research team at Yale says that they have identified how to repair broken strands of DNA responsible for cancer. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.